Dr. Gabriel Vogel

Allergist · Uniklinik Köln · Germany (DE) · Immunology

Tier 1STK-0152GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Inflammatory skin disease
Disease interests: AD
Scientific interests: Long-term safetyJAK selectivity
Engagement preference: Virtual
Advisory boards: 1
Publications: 60
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 17 Jan 2026 (241 days ago)
Next planned contact: 18 Apr 2026 Overdue
Last 6 months vs target: 0%
0 of 2 expected engagements

Insights from this stakeholder (1)

INS-0078Phase IIb efficacy
19 Jan 2026 · Product understanding
MediumClosed

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
17 Jan 2026	Advisory board	Virtual	Rachel Adeyemi	Aurelin	Phase IIb efficacyAdolescent population+1	1	—	Reviewed	ENG-0231

Timeline

17 Jan 2026
Advisory board
Phase IIb efficacy, Adolescent population, JAK1/TYK2 selectivity

Related stakeholders (6)

Uniklinik Köln

Dr. Mariana Sato
Thoracic medical oncologist
Tier 2
Dr. Emiko Tanaka
Thoracic medical oncologist
Tier 1
Dr. Rosa Jensen
Community nephrologist
Tier 3
Dr. Emiko Garcia
Academic nephrologist
Tier 3
Dr. William Vogel
Community nephrologist
Tier 2
Dr. Liam Olsen
Dermatologist
Tier 2